COVINGTON, Ky., July 1, 2020 /PRNewswire/ -- Gravity
Diagnostics, a CLIA laboratory headquartered in Covington, Kentucky, today announced the U.S.
Food and Drug Administration (FDA) has granted an update to their
Emergency Use Authorization (EUA) to include use of nasal swab
specimens that are self-collected by individuals using the
Kroger Health COVID-19 Test Home Collection Kit. This was an
addition to their earlier EUA that was granted on June 1st, 2020. The testing solution
combines the safety and convenience of at-home specimen collection
with the expert guidance of a Kroger Health clinician through video
telehealth visit.
On March 16th, Gravity Diagnostics
began processing COVID-19 samples with a vision to bring increased
testing to their local communities, partnering with the
Commonwealth of Kentucky to serve
the healthcare facilities across the state and later with Kroger
Health to bring more testing to Kentucky and nationwide via drive through
testing sites. This next big step with Kroger Health will allow the
two organizations to make a more widespread impact for COVID-19
testing across the nation, through an innovative method focused on
quality, compliance, and patient experience.
Kroger Health will make the kits available to frontline
associates across Kroger's Family of Companies based on medical
need first, and will expand rapidly from there, with a goal of
processing up to 60,000 per week by the end of July. Gravity
Diagnostics to date has processed over 250,000 COVID-19 samples.
The relatively small laboratory is evolving quickly to meet the
need and scale through hiring of personnel and expansion of
equipment and new laboratory space.
"Everything we have done during this time is with the people of
our communities and nation in mind. After partnering with Kroger
Health to execute their nationwide drive throughs, we were
enthusiastic to continue to expand testing through our partnership
in a way that is flexible and accessible during this critical time
of working to reopen the United
States," said Tony Remington,
CEO of Gravity Diagnostics. "We are humbled to be a part of just
one of the ways Kroger Health is executing a larger vision of how
the healthcare industry is evolving."
About Gravity Diagnostics
Gravity Diagnostics is a
full-service state-of-the-art CLIA laboratory licensed in all 50
states providing innovative laboratory testing including Infectious
Disease (Upper Respiratory and Sexually Transmitted), Toxicology,
and Pharmacogenomics. We are an advocate for physicians, patients,
and our communities, supporting them with unsurpassed integrity,
regulatory compliance, and clinical expertise. Learn more by
visiting gravitydiagnostics.com.
About Kroger Health:
Kroger Health, the healthcare division of The Kroger Co., is one of
America's leading retail healthcare organizations, with over 2,000
pharmacies and 200 clinics in 35 states serving more than 14
million customers. Their team of 22,000 healthcare practitioners -
from pharmacists and nurse practitioners, to dietitians and
technicians – are committed to helping people live healthier lives.
They believe in practicing at the top of our licenses and enabling
"food as medicine" to help prevent or manage certain diseases.
Learn more at www.krogerhealth.com.
About The Kroger Co.:
At The Kroger Co. (NYSE: KR), we
are Fresh for Everyone™ and dedicated to their Purpose:
To Feed the Human Spirit®. They are, across our family of
companies, nearly half a million associates who serve over 11
million customers daily through a seamless shopping experience
under a variety of banner names. They are committed to
creating #ZeroHungerZeroWaste communities by 2025. To learn more
about them, visit their newsroom and investor
relations site.
Contact: media@gravitydiagnostics.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/gravity-diagnostics-partners-with-kroger-health-to-expand-covid-19-testing-with-home-collection-kits-301087167.html
SOURCE Gravity Diagnostics